MiWa Technologies has developed the Cardiopulmonary Stethoscope, a low-cost, non-invasive integrated radio frequency-based system for lung water and vital sign measurements.
Being able to closely monitor the changes in lung water, respiratory rate, and heart rate, are the foundation for proactively preventing worsening of patients’ heart failure.
5.1 million people in the United States have Heart Failure, 23 million worldwide
550,000 new patients every year in the U.S.
Heart Failure costs $39 billion annually in the U.S.